Results 161 to 170 of about 74,008 (304)
The prognostic value of <i>KRAS, NRAS</i>, and <i>BRAF</i> genes mutations in patients with newly diagnosed multiple myeloma. [PDF]
Pham PT, Nguyen HV, Vu MP.
europepmc +1 more source
Summary Patient‐reported outcome (PRO) and quality of life (QoL) assessments for multiple myeloma (MM) patients are traditionally collected at infrequent intervals using burdensome instruments, resulting in limited clinical visibility between visits. This creates a critical gap in care, as evolving symptoms and treatment‐related toxicities frequently ...
Victor Tellez +12 more
wiley +1 more source
Mapping the de-implementation of traditional diagnostic tests in pediatric acute lymphoblastic leukemia. [PDF]
Salek M +8 more
europepmc +1 more source
Summary Venetoclax plus anti‐CD20 monoclonal antibody (mAb) regimens have revolutionised treatment for chronic lymphocytic leukaemia (CLL); however, CD20 antigen loss is a potential consequence. Given emerging roles for re‐treatment with venetoclax plus anti‐CD20 mAb and CD20‐targeting bispecific antibodies in CLL, we retrospectively assessed the ...
Tamasine Stewart +15 more
wiley +1 more source
From Chromosomes to Precision Therapy: Clinical Cytogenetics and Cytogenomics in the Era of Genomic Medicine. [PDF]
Liu J.
europepmc +1 more source
Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement. [PDF]
Xiao A +19 more
europepmc +1 more source
Evaluation of an Artificial Intelligence-Assisted Metaphase Finder for Clinical Cytogenetic Application. [PDF]
Dawson BJ +3 more
europepmc +1 more source
Molecular heterogeneity and prognostic biomarkers in primary meningeal melanocytic tumors
Integrated molecular profiling reveals biological heterogeneity among primary meningeal melanocytic tumors, identifying intermediate‐grade PMMT subgroups with distinct recurrence risk. Molecular alterations including SF3B1 mutations and chromosome 8q gains support prognostic stratification, while PRKAR1A alterations and chromosome 17/21q losses aid ...
Rosina Paterra +6 more
wiley +1 more source
Chronic lymphocytic leukemia (CLL) is much less prevalent in Taiwan than in the West, but we have recently addressed the distinctly increasing incidence of CLL in Taiwan. We sought to find out whether there is any difference in cytogenetic abnormalities (
Wu, Shang-Ju;Lin, Chien-Ting;Huang, Sheng-Yi;Lee, Fen-Yu;Liu, Ming-Chi;Hou, Hsin-An;Chen, Chien-Yuan;Ko, Bor-Sheng;Chou, Wen-Chien;Yao, Ming;Tang, Jih-Luh;Tsay, Woei;Tien, Hwei-Fang +1 more
core

